This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Paul W. Barone
Advertisement
Articles by Paul W. Barone
MIT survey results address product and site characteristics that statistically correlate with quality performance.
Advertisement
Latest Updated Articles
The Impact of SARS-CoV-2 on Biomanufacturing OperationsAugust 4th 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
5